C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress

[1]  I. Ferrer,et al.  Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS , 2011, Acta Neuropathologica.

[2]  E. Huey,et al.  FTD and ALS: a tale of two diseases. , 2011, Current Alzheimer research.

[3]  G. Rouleau,et al.  TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. , 2011, Human molecular genetics.

[4]  J. Julien,et al.  ALS pathogenesis: Recent insights from genetics and mouse models , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  J. Vickers,et al.  Neuron–glia interactions underlie ALS-like axonal cytoskeletal pathology , 2011, Neurobiology of Aging.

[6]  D. Ito,et al.  Nuclear transport impairment of amyotrophic lateral sclerosis‐linked mutations in FUS/TLS , 2011, Annals of neurology.

[7]  Daniel R. Dries,et al.  TDP-43 Is Directed to Stress Granules by Sorbitol, a Novel Physiological Osmotic and Oxidative Stressor , 2010, Molecular and Cellular Biology.

[8]  L. Petrucelli,et al.  Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue , 2010, PloS one.

[9]  I. Mackenzie,et al.  TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.

[10]  I. Blair,et al.  TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. , 2010, The international journal of biochemistry & cell biology.

[11]  I. Mackenzie,et al.  ALS‐associated fused in sarcoma (FUS) mutations disrupt Transportin‐mediated nuclear import , 2010, The EMBO journal.

[12]  T. Hortobágyi,et al.  Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. , 2010, Brain : a journal of neurology.

[13]  C. Masters,et al.  Zinc induces depletion and aggregation of endogenous TDP-43. , 2010, Free radical biology & medicine.

[14]  R. Flavell,et al.  JNK3 Mediates Paraquat- and Rotenone-Induced Dopaminergic Neuron Death , 2010, Journal of neuropathology and experimental neurology.

[15]  John Q. Trojanowski,et al.  TAR DNA-binding protein 43 in neurodegenerative disease , 2010, Nature Reviews Neurology.

[16]  E. Choi,et al.  Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.

[17]  P. Shaw,et al.  Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. , 2010, Free radical biology & medicine.

[18]  M. Bogoyevitch,et al.  c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. , 2010, Biochimica et biophysica acta.

[19]  R. Chitta,et al.  Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. , 2010, Journal of proteome research.

[20]  A. Bhattacharyya,et al.  Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53 , 2010, International journal of cancer.

[21]  A. Aronheim,et al.  A Novel c-Jun N-terminal Kinase (JNK)-binding Protein WDR62 Is Recruited to Stress Granules and Mediates a Nonclassical JNK Activation , 2010, Molecular biology of the cell.

[22]  R. Parker,et al.  Eukaryotic stress granules: the ins and outs of translation. , 2009, Molecular cell.

[23]  H. Koh,et al.  Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. , 2009, Toxicology letters.

[24]  M. Strong,et al.  Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) , 2009, Brain Research.

[25]  M. Iwashima,et al.  hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation. , 2009, International immunology.

[26]  D. Ito,et al.  Characterization of Alternative Isoforms and Inclusion Body of the TAR DNA-binding Protein-43* , 2009, The Journal of Biological Chemistry.

[27]  E. Buratti,et al.  TDP‐43 is recruited to stress granules in conditions of oxidative insult , 2009, Journal of neurochemistry.

[28]  R. Kalb,et al.  A Switch in Retrograde Signaling from Survival to Stress in Rapid-Onset Neurodegeneration , 2009, The Journal of Neuroscience.

[29]  E. Kremmer,et al.  Proteolytic processing of TAR DNA binding protein‐43 by caspases produces C‐terminal fragments with disease defining properties independent of progranulin , 2009, Journal of neurochemistry.

[30]  H. Akiyama,et al.  Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43 , 2009, Alzheimer's & Dementia.

[31]  N. Shimada,et al.  p38 MAP Kinase-dependent regulation of the expression level and subcellular distribution of heterogeneous nuclear ribonucleoprotein A1 and its involvement in cellular senescence in normal human fibroblasts , 2009, RNA biology.

[32]  A. D’Ambrogio,et al.  Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo , 2009, Nucleic acids research.

[33]  L. Petrucelli,et al.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.

[34]  P. Leigh,et al.  Riluzole protects against glutamate-induced slowing of neurofilament axonal transport , 2009, Neuroscience Letters.

[35]  J. Trojanowski,et al.  Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies* , 2009, Journal of Biological Chemistry.

[36]  H. Akiyama,et al.  Phosphorylated and ubiquitinated TDP‐43 pathological inclusions in ALS and FTLD‐U are recapitulated in SH‐SY5Y cells , 2009, FEBS letters.

[37]  M. Strong,et al.  Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury , 2009, Brain Research.

[38]  Maurizio Pellecchia,et al.  Identification of a new JNK inhibitor targeting the JNK-JIP interaction site , 2008, Proceedings of the National Academy of Sciences.

[39]  C. L. Costantino,et al.  Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells , 2008, Cancer biology & therapy.

[40]  A. Isaacs,et al.  TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander , 2008, Mammalian Genome.

[41]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[42]  P. Shaw,et al.  Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. , 2006, Biochimica et biophysica acta.

[43]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[44]  S. Guil,et al.  hnRNP A1 Relocalization to the Stress Granules Reflects a Role in the Stress Response , 2006, Molecular and Cellular Biology.

[45]  J. Julien,et al.  Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS , 2006, Molecular and Cellular Neuroscience.

[46]  E. Buratti,et al.  TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail , 2005, Journal of Biological Chemistry.

[47]  Rodolfo Marquez,et al.  The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1. , 2005, Immunity.

[48]  G. Perry,et al.  Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway , 2003, Redox report : communications in free radical research.

[49]  B. Ghetti,et al.  Activation of the JNK/p38 Pathway Occurs in Diseases Characterized by Tau Protein Pathology and Is Related to Tau Phosphorylation But Not to Apoptosis , 2001, Journal of neuropathology and experimental neurology.

[50]  A L Burlingame,et al.  Identification of New JNK Substrate Using ATP Pocket Mutant JNK and a Corresponding ATP Analogue* , 2001, The Journal of Biological Chemistry.

[51]  Kavita Shah,et al.  ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation , 2001, Nature Cell Biology.

[52]  D. Troost,et al.  c‐Jun, JNK/SAPK Kinase and Transcription Factor NF-κB Are Selectively Activated in Astrocytes, but not Motor Neurons, in Amyotrophic Lateral Sclerosis , 1997, Journal of neuropathology and experimental neurology.

[53]  S. Finkbeiner,et al.  Pathogenic TARDBP Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Disease-Associated Pathways , 2010, Reviews in the neurosciences.